ATAI Life Sciences

About:

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

Website: http://atai.life

Twitter/X: ATAI_life

Top Investors: Hercules Capital, Gaingels, Catalio Capital Management, FJ Labs, What If Ventures

Description:

ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.

Total Funding Amount:

$522M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Munich, Bayern, Germany

Founded Date:

2018-01-01

Contact Email:

info(AT)atai.life

Hub Tags:

Exited Unicorn

Founders:

Christian Angermayer, Florian Brand, Lars Christian Wilde, Srinivas Rao

Number of Employees:

101-250

Last Funding Date:

2022-08-15

IPO Status:

Public

© 2025 bioDAO.ai